Roadzen director granted 190,915 stock options
Roadzen Inc. director Diane Beth Glossman reported a new stock option grant.
Rhea-AI Filing Summary
Roadzen Inc. director Diane Beth Glossman reported a new stock option grant. On September 15, 2025, she was awarded 190,915 stock options giving her the right to buy up to 190,915 ordinary shares. The options have an exercise price of $2 per share, were first exercisable on September 15, 2025, and expire on September 15, 2032. The Form 4 shows she now directly holds 190,915 derivative securities following this grant, and the options were granted at no cash cost to her.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 190,915 | $0.00 | $0.00 |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Roadzen (RDZN) report in this Form 4?
Roadzen (RDZN) reported that director Diane Beth Glossman received a grant of 190,915 stock options on September 15, 2025.
What are the key terms of Diane Beth Glossman’s Roadzen (RDZN) stock options?
The grant covers 190,915 stock options with an exercise price of $2 per share, first exercisable on September 15, 2025 and expiring on September 15, 2032.
How many Roadzen (RDZN) derivative securities does Diane Beth Glossman own after this transaction?
After the reported grant, Diane Beth Glossman beneficially owns 190,915 derivative securities (stock options) directly.
Did Diane Beth Glossman pay anything to receive these Roadzen (RDZN) options?
The Form 4 shows a $0 price for the derivative security, indicating the options were granted at no cash cost to her.
What type of security did Diane Beth Glossman receive from Roadzen (RDZN)?
She received a stock option (right to buy) that can be exercised into ordinary shares of Roadzen Inc.
AI-generated analysis. How Rhea-AI works. Not financial advice.